Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enriched-CRT 2017: Adjuvant Chemoradiotherapy vs Chemotherapy in Advanced Gastric Cancer
NCT03680261Phase 3Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2018
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gastric cancer (GC) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03680261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680261.